1-11C-acetate versus 18F-FDG PET in detection of meningioma and monitoring the effect of γ-knife radiosurgery

Journal of Nuclear Medicine

Volumn 51, Issue 6, 2010, Pages 883-891

  Liu, Ren Shyan ^a,b   Chang, Chen Pei ^b   Guo, Wen You ^a   Pan, David H C ^a   Ho, Donald Ming Tak ^a   Chang, Chi Wei ^a   Yang, Bang Hung ^a,b   Wu, Liang Chi ^a,b   Yeh, Shin Hwa ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

1 11C acetate; 18F FDG; Meningioma; Positron emission tomography; Radiosurgery

Indexed keywords

ACETIC ACID C 11; FLUORODEOXYGLUCOSE F 18; ACETIC ACID DERIVATIVE; CARBON; CARBON 11 ACETATE; CARBON-11 ACETATE; DIAGNOSTIC AGENT;

ADULT; AGED; ARTICLE; BRAIN CORTEX; CANCER DIAGNOSIS; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DISEASE SEVERITY; FEMALE; GAMMA KNIFE RADIOSURGERY; HISTOPATHOLOGY; HUMAN; MALE; MENINGIOMA; OUTCOME ASSESSMENT; PATIENT MONITORING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RECURRENT DISEASE; THERAPY EFFECT; COMPARATIVE STUDY; METABOLISM; METHODOLOGY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; RADIOSURGERY; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; SCINTISCANNING; TRANSPORT AT THE CELLULAR LEVEL; TREATMENT OUTCOME; TUMOR VOLUME;

ACETATES; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL TRANSPORT; CARBON; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MENINGIOMA; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOSURGERY; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 77953931098     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.109.070565     Document Type: Article

References (48)

1. Black PM. Brain tumors (second of two parts). N Engl J Med. 1991;324:1555-1564.
2. Rausing A, Ybo W, Stenflo J. Intracranial meningioma: a population study of ten years. Acta Neurol Scand. 1970;46:102-110.
3. Quest Do. Meningiomas: an update. Neurosurgery. 1978;3:219-225.
4. Carella RJ, Ransohoff J, Newell J. Role of radiation therapy in the management of meningioma. Neurosurgery. 1982;10:332-339.
5. Coke CC, Corn BW, Werner-Wasik M, Xie Y, Curran WJ Jr. Atypical and malignant meningiomas: an outcome report of seventeen cases. J Neurooncol. 1998;39:65-70.
6. 18F] fluorodeoxyglucose in brain tumors: a powerful diagnostic and prognostic tool. Invest Radiol. 1987;22:360-371.
7. Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Assessment: positron emission tomography. Neurology. 1991;41:163-166.
8. Warburg O. On the origin of cancer cells. Science. 1956;123:309-314.
9. Mahaley MS Jr. In vitro respiration of normal brain and brain tumors. Cancer Res. 1966;26:195-197.
10. Ericson K, Lilja A, Bergstrom M, et al. Positron emission tomography with [11-C-methyl]-L-methionine, [11-C]-D-glucose and [68-Ga]EDTA in supratentorial tumors. J Comput Assist Tomogr. 1985;9:683-689.
11. Di Chiro G, Hatazawa J, Katz DA, Rizyoli HV, De Michele DJ. Glucose utilization by intracranial meningiomas as an index of tumor aggressivity and probability of recurrence: a PET study. Radiology. 1987;164:521-526.
12. Cremerius U, Bares R, Weis J, et al. Fasting improves discrimination of grade 1 and atypical or malignant meningioma in FDG-PET. J Nucl Med. 1997;38:26-30.
13. Delbeke D, Myerowitz C, Lapidus RI, et al. Optimal cutoff levels of F-18-fluorodeoxyglucose uptake in differentiation of low-grade from high grade brain tumors with PET. Radiology. 1995;195:47-52.
14. 11C-L-methiomine PET. Eur J Nucl Med. 2000;27:1793-1799.
15. 18F] Fluoroethyl-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas. Brain. 2005;128:678-687.
16. Pruim J, Willemsen ATM, Molenaar WM, et al. Brain tumors: l-[1-C-11] tyrosine PET for visualization and quantification of protein synthesis rate. Radiology. 1995;197:221-226.
17. Shinoura N, Nishijima M, Hara T, et al. Brain tumors: detection with C-11 choline PET. Radiology. 1997;202:497-503.
18. Shreve P, Chiao PC, Humes D, Schwaiger M, Gross MD. Carbon-11-acetate PET imaging in renal disease. J Nucl Med. 1995;36:1595-1601.
19. 11C-acetate clearance in nasopharyngeal carcinoma. Nucl Med Commun. 1999;20:131-134.
20. 11C-acetate PET imaging of prostate cancer. J Nucl Med. 2002;43:181-186.
21. 11C-acetate PET imaging in hepatocellular carcinoma and other liver masses. J Nucl Med. 2003;44:213-221.
22. 11carbon-acetate. Eur J Nucl Med Mol Imaging. 2006;33:420-427.
23. 14C]acetate. J Nucl Med. 2001;42:1243-1250.
24. Kleihues P, Burger PC, Scheithauer BW. The new WHO classification of brain tumors. Brain Pathol. 1993;3:255-268.
25. Ho DMT, Hsu CY, Ting LT, Chiang H. Histopathology and MIB-1 labeling index predicted recurrence of meningiomas. Cancer. 2002;94:1538-1547.
26. 11C]acetate: an agent for the study of myocardial metabolism by positron emission tomography. Int J Appl Radiat Isot. 1982;33:505-512.
27. 18F]fluoro-2-deoxyglucose using aminopolyester supported nucleophilic substitution. J Nucl Med. 1986;27:235-238.
28. Ogawa T, Shishide F, Kanno I, et al. Cerebral gliomas: evaluation with methionine-PET. Radiology. 1993;186:45-53.
29. Kaschten B, Stevenaert A, Sadzot B, et al. Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine. J Nucl Med. 1998;39:778-785.
30. Hertz L, Peng L, Dienel GA. Energy metabolism in astrocytes: high rate of oxidative metabolism and spatiotemporal dependence on glycolysis/ glycogenolysis. J Cereb Blood Flow Metab. 2007;27:219-249.
31. Cruz NF, Lasater A, Zielke HR, Dienel GA. Activation of astrocytes in brain of conscious rat during acoustic stimulation: acetate utilization in working brain. J Neurochem. 2005;92:934-947.
32. Dienel GA, Schimidt KC, Cruz NF. Astrocyte activation in vivo during graded photic stimulation. J Neurochem. 2007;103:1506-1522.
33. 2 during the infusion of C-1-vs C-2-labeled acetate: implications for tracer studies of substrate oxidation. Am J Clin Nutr. 1990;51:248-252.
34. 13C-acetate. Metabolism. 1998;47:549-554.
35. Goldman S, Levivier M, Pirotte B, et al. Regional glucose metabolism and histopathology of gliomas: a study based on positron emission tomography-guided stereotactic biopsy. Cancer. 1996;78:1098-1106.
36. 14C-acetate in sensorimotor cortex, thalamus, caudate nucleus and cerebellum of the cat. J Neurochem. 1968;15:965-970.
37. 14C-labeled acetate and butyrate in rat brain in vivo during spreading cortical depression. J Neurosci Res. 2001;66:812-820.
38. Yoshimoto M, Waki A, Yonekura Y, et al. Characterization of acetate metabolism in tumor cells in relation to cell proliferation: acetate metabolism in tumor cells. Nucl Med Biol. 2001;28:117-122.
39. 11C-acetate. J Nucl Med. 2007;48:420-428.
40. Yoshii Y, Waki A, Furukawa T, et al. Tumor uptake of radiolabeled acetate reflects the expression of cytosolic acetyl-CoA synthetase: implications for the mechanism of acetate PET. Nucl Med Biol. 2009;36:771-777.
41. 18F-FDG-PET. Eur J Nucl Med Mol Imaging. 2002;29:176-182.
42. 11C-methioninefor PET-guided stereotactic brain biopsy of gliomas. J Nucl Med. 2004;45:1293-1298.
43. Steiner L, Lindquist C, Steiner M. Meningiomas and gamma knife radiosurgery. In: Al-Mefty O, ed. Meningiomas. New York, NY: Raven Press, Ltd.; 1991: 263-272.
44. Pan DHC, Guo WY, Chung WY, Shian CY, Liu RS, Lee LS. Early effects of gamma knife surgery on malignant and benign intracranial tumors. Stereotact Funct Neurosurg. 1995;64(suppl 1):19-31.
45. +-immunoreactive cells. Neurochem Int. 2003;42:359-374.
46. 18F-FAc in a sarcoma and inflammationbearing mouse model. Nucl Med Biol. 2009;36:305-312.
47. Morrison JF, Peters RA. Biochemistry of fluoroacetate poisoning: the effect of fluorocitrate on purified aconitase. Biochem J. 1954;58:473-499.
48. Fonnum F, Johnsen A, Hassel B. Use of fluorocitrate and fluoroacetate in the study of brain metabolism. Glia. 1997;21:106-113.